Ad-IFNa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ad-IFNa, covering 2016-11-28 to 2016-11-28. Get the full timeline:
Most recent: Clinical Trial Update: 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer [Phase 1]